Differential effects of GABAB receptor subtypes, γ-hydroxybutyric acid, and baclofen on EEG activity and sleep regulation

Journal of Neuroscience

Volumn 30, Issue 42, 2010, Pages 14194-14204

  Vienne, Julie ^a   Bettler, Bernhard ^b   Franken, Paul ^a   Tafti, Mehdi ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; BACLOFEN; GAMMA BUTYROLACTONE; RECEPTOR SUBUNIT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; INTRAVENOUS ANESTHETIC AGENT; OXYBATE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAM; HYPERSOMNIA; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; SLEEP; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; DELTA RHYTHM; ELECTRODE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EPILEPSY; GENETICS; MOUSE MUTANT; PATHOPHYSIOLOGY; REM SLEEP; SLEEP DEPRIVATION; THETA RHYTHM;

ANESTHETICS, INTRAVENOUS; ANIMALS; BACLOFEN; BEHAVIOR, ANIMAL; DELTA RHYTHM; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EPILEPSY; GABA AGONISTS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, GABA-B; SLEEP; SLEEP DEPRIVATION; SLEEP, REM; SODIUM OXYBATE; THETA RHYTHM;

EID: 77958586336     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3145-10.2010     Document Type: Article

References (77)

1. Bessman SP, Fishbein WN (1963) Gamma-hydroxybutyrate, a normal brain metabolite. Nature 200:1207-1208.
2. Biggs KR, Prosser RA (1998) GABAB receptor stimulation phase-shifts the mammalian circadian clock in vitro. Brain Res 807:250-254.
3. Black J, Houghton WC (2006) Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep 29:939-946.
4. Black J, Pardi D, Hornfeldt CS, Inhaber N (2009) The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Sleep Med 10:829-835.
5. Borbély AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557-568.
6. Carai MA, Lobina C, Maccioni P, Cabras C, Colombo G, Gessa GL (2008) Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone. J Pharmacol Sci 106:199-207.
7. Carter LP, Koek W, France CP (2006) Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats. Eur J Neurosci 24:2595-2600. (Pubitemid 44726771)
8. Cash CD (1994) Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 18:291-304.
9. Castelli MP, Pibiri F, Carboni G, Piras AP (2004) A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor. CNS Drug Rev 10:243-260. (Pubitemid 39391317)
10. Crosio C, Cermakian N, Allis CD, Sassone-Corsi P (2000) Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci 3:1241-1247.
11. Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Lüscher C (2004) Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7:153-159. (Pubitemid 38129791)
12. Darbari FP, Melvin JJ, Piatt JH Jr, Adirim TA, Kothare SV (2005) Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features. Pediatr Neurol 33:373-377.
13. de Fiebre CM, de Fiebre NE, Coleman SL, Forster MJ (2004) Comparison of the actions of gamma-butyrolactone and 1,4-butanediol in Swiss-Webster mice. Pharmacol Biochem Behav 77:705-710.
14. Dijk DJ, Beersma DG (1989) Effects of SWS deprivation on subsequent EEG power density and spontaneous sleep duration. Electroencephalogr Clin Neurophysiol 72:312-320.
15. Doherty JD, Hattox SE, Snead OC, Roth RH (1978) Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. J Pharmacol Exp Ther 207:130-139.
16. Filip M, Frankowska M (2008) GABA(B) receptors in drug addiction. Pharmacol Rep 60:755-770.
17. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD (1995) The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 8:230-234.
18. Franken P, Malafosse A, Tafti M (1998) Genetic variation in EEG activity during sleep in inbred mice. Am J Physiol 275:R1127-R1137. (Pubitemid 28498637)
19. Franken P, Malafosse A, Tafti M (1999) Genetic determinants of sleep regulation in inbred mice. Sleep 22:155-169. (Pubitemid 29143214)
20. Franken P, Chollet D, Tafti M (2001) The homeostatic regulation of sleep need is under genetic control. J Neurosci 21:2610-2621. (Pubitemid 32298203)
21. Fuller DE, Hornfeldt CS (2003) From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205-1209.
22. Gambardella A, Manna I, Labate A, Chifari R, La Russa A, Serra P, Cittadella R, Bonavita S, Andreoli V, LePiane E, Sasanelli F, Di Costanzo A, Zappia M, Tedeschi G, Aguglia U, Quattrone A (2003) GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 60:560-563. (Pubitemid 36246069)
23. Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S, Humeau Y, Schuler V, Müller M, Kinzel B, Klebs K, Schmutz M, Froestl W, Heid J, Kelly PH, Gentry C, Jaton AL, Van der Putten H, Mombereau C, Lecourtier L, et al. (2004) Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci 24:6086-6097.
24. Godschalk M, Dzoljic MR, Bonta IL (1977) Slow wave sleep and a state resembling absence epilepsy induced in the rat by gamma-hydroxybutyrate. Eur J Pharmacol 44:105-111. (Pubitemid 8112856)
25. Guilleminault C, Flagg W (1984) Effect of baclofen on sleep-related periodic leg movements. Ann Neurol 15:234-239. (Pubitemid 14164737)
26. Hasan S, Pradervand S, Ahnaou A, Drinkenburg W, Tafti M, Franken P (2009) How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion. Neuropsychopharmacology 34:1625-2640.
27. Huang YS, Guilleminault C (2009) Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Pediatr Neurol 41:9-16.
28. Huguenard JR, Prince DA (1994) Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. J Neurosci 14:5485-5502.
29. Hulme A, MacLennan WJ, Ritchie RT, John VA, Shotton PA (1985) Baclofen in the elderly stroke patient its side-effects and pharmacokinetics. Eur J Clin Pharmacol 29:467-469. (Pubitemid 16192605)
30. Jacobson LH, Bettler B, Kaupmann K, Cryan JF (2007a) Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) 190:541-553.
31. Jacobson LH, Kelly PH, Bettler B, Kaupmann K, Cryan JF (2007b) Specific roles of GABA(B(1)) receptor isoforms in cognition. Behav Brain Res 181:158-162. (Pubitemid 46765008)
32. Jensen K, Mody I (2001) GHB depresses fast excitatory and inhibitory synaptic transmission via GABA(B) receptors in mouse neocortical neurons. Cereb Cortex 11:424-429. (Pubitemid 32428068)
33. Juhász G, Emri Z, Kékesi KA, Salfay O, Crunelli V (1994) Blockade of thalamic GABAB receptors decreases EEG synchronization. Neurosci Lett 172:155-158. (Pubitemid 24178766)
34. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, Bräuner-Osborne H, Waldmeier P, Bettler B (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730. (Pubitemid 37542125)
35. Kim U, Sanchez-Vives MV, McCormick DA (1997) Functional dynamics of GABAergic inhibition in the thalamus. Science 278:130-134. (Pubitemid 27446293)
36. Koek W, France CP (2008) Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists. Psychopharmacology (Berl) 199:191-198.
37. Koek W, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, France CP (2005) Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam. J Pharmacol Exp Ther 314:170-179. (Pubitemid 41058253)
38. Koek W, Mercer SL, Coop A (2007) Cataleptic effects of gammahydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology (Berl) 192:407-414.
39. Laborit H (1964) Sodium 4-hydroxybutyrate. Int J Neuropharmacol 3:433-451.
40. Laborit H, Jouany JM, Gerard J, Fabiani F (1960) Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate. Presse Med 68:1867-1869.
41. Lapierre O, Montplaisir J, Lamarre M, Bedard MA (1990) The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep 13:24-30. (Pubitemid 20039775)
42. Levin ED, Weber E, Icenogle L (2004) Baclofen interactions with nicotine in rats: effects on memory. Pharmacol Biochem Behav 79:343-348. (Pubitemid 40029238)
43. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667-1673. (Pubitemid 29430241)
44. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361.
45. Mamelak M, Escriu JM, Stokan O (1977) The effects of gamma- hydroxybutyrate on sleep. Biol Psychiatry 12:273-288.
46. Mamelak M, Black J, Montplaisir J, Ristanovic R (2004) A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 27:1327-1334. (Pubitemid 44138899)
47. Matsuki T, Nomiyama M, Takahira H, Hirashima N, Kunita S, Takahashi S, Yagami K, Kilduff TS, Bettler B, Yanagisawa M, Sakurai T (2009) Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci U S A 106:4459-4464.
48. Meerlo P, Westerveld P, Turek FW, Koehl M (2004) Effects of gamma-hydroxybutyrate (GHB) on vigilance states and EEG in mice. Sleep 27:899-904. (Pubitemid 39095722)
49. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF (2004) Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 29:1050-1062. (Pubitemid 38670043)
50. Monti JM, Altier H, D'Angelo L (1979) The effects of the combined administration of gamma-hydroxybutyrate and diazepam on sleep parameters in the rat. J Neural Transm 45:177-183. (Pubitemid 9163025)
51. Novak CM, Ehlen JC, Huhman KL, Albers HE (2004) GABA(B) receptor activation in the suprachiasmatic nucleus of diurnal and nocturnal rodents. Brain Res Bull 63:531-535. (Pubitemid 38891863)
52. Pérez-Garci E, Gassmann M, Bettler B, Larkum ME (2006) The GABAB1b isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons. Neuron 50:603-616.
53. Quéva C, Bremner-Danielsen M, Edlund A, Ekstrand AJ, Elg S, Erickson S, Johansson T, Lehmann A, Mattsson JP (2003) Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice. Br J Pharmacol 140:315-322.
54. Ralph MR, Menaker M (1989) GABA regulation of circadian responses to light. I. Involvement of GABAA-benzodiazepine and GABAB receptors. J Neurosci 9:2858-2865.
55. Roberts DC (2005) Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol Behav 86:18-20.
56. Roth RH, Delgado JM, Giarman NJ (1966) Gamma-butyrolactone and gamma-hydroxybutyric acid. II. The pharmacologically active form. Int J Neuropharmacol 5:421-428.
57. Roth RH, Levy R, Giarman NJ (1967) Dependence of rat serum lactonase upon calcium. Biochem Pharmacol 16:596-598.
58. Rubin BA, Giarman NJ (1947) The therapy of experimental influenza in mice with antibiotic lactones and related compounds. Yale J Biol Med 19:1017-1022.
59. Schuler V, Lüscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Käslin E, Korn R, et al. (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31:47-58.
60. Schwartz WJ, Zimmerman P (1990) Circadian timekeeping in BALB/c and C57BL/6 inbred mouse strains. J Neurosci 10:3685-3694.
61. Schwenk J, Metz M, Zolles G, Turecek R, Fritzius T, Bildl W, Tarusawa E, Kulik A, Unger A, Ivankova K, Seddik R, Tiao JY, Rajalu M, Trojanova J, Rohde V, Gassmann M, Schulte U, Fakler B, Bettler B (2010) Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465:231-235.
62. Shimomura K, Low-Zeddies SS, King DP, Steeves TD, Whiteley A, Kushla J, Zemenides PD, Lin A, Vitaterna MH, Churchill GA, Takahashi JS (2001) Genome-wide epistatic interaction analysis reveals complex genetic determinants of circadian behavior in mice. Genome Res 11:959-980. (Pubitemid 32834543)
63. Snead OC 3rd (1991) The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology 30:161-167.
64. Stock G, Heidt H, Buss J, Schlör KH (1978) Sleep patterns in cat induced by gammahydroxybutyric acid. Electroencephalogr Clin Neurophysiol 44:523-527. (Pubitemid 8325148)
65. Ulloor J, Mavanji V, Saha S, Siwek DF, Datta S (2004) Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat. J Neurophysiol 91:1822-1831. (Pubitemid 38339350)
66. Ulrich D, Bettler B (2007) GABA(B) receptors: synaptic functions and mechanisms of diversity. Curr Opin Neurobiol 17:298-303. (Pubitemid 46880321)
67. U.S. Xyrem Multicenter Study Group (2003) A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 26:31-35.
68. Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L'Hermite-Balériaux M, Copinschi G (1997) Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 100:745-753. (Pubitemid 27340524)
69. van Lier H, Coenen AM, Drinkenburg WH (2003) Behavioral transitions modulate hippocampal electroencephalogram correlates of open field behavior in the rat: support for a sensorimotor function of hippocampal rhythmical synchronous activity. J Neurosci 23:2459-2465.
70. van Nieuwenhuijzen PS, McGregor IS, Hunt GE (2009) The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen. Neuroscience 158:441-455.
71. Vertes RP (2005) Hippocampal theta rhythm: a tag for short-term memory. Hippocampus 15:923-935.
72. Vickers MD (1969) Gammahydroxybutyric acid. Int Anesthesiol Clin 7:75-89.
73. Vigot R, Barbieri S, Bräuner-Osborne H, Turecek R, Shigemoto R, Zhang YP, Luján R, Jacobson LH, Biermann B, Fritschy JM, Vacher CM, Müller M, Sansig G, Guetg N, Cryan JF, Kaupmann K, Gassmann M, Oertner TG, Bettler B (2006) Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron 50:589-601.
74. Waldmeier PC (1991) The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 343:173-178.
75. Winsky-Sommerer R (2009) Role of GABAA receptors in the physiology and pharmacology of sleep. Eur J Neurosci 29:1779-1794.
76. Xyrem International Study Group (2005) Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 6:415-421.
77. Zarrindast M, Valizadeh S, Sahebgharani M (2000) GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice. Eur J Pharmacol 407:65-72.